Skip to content
Sign in

Company

Suzhou Ribo Life Science

Open structure map

Structure of Suzhou Ribo Life Science

Suzhou Ribo Life Science

Company

4 connections
UpstreamSupply and dependency
PeersCompetition and partners
OwnProducts and technology
Relationship began2026
Suzhou Ribo Life ScienceCompany · 4 connections
Layer 1

UpstreamSupply and dependency1

PeersCompetition and partners1

OwnProducts and technology2

Place in the network

No. 9878 of 118934top 9%down 1191 places this week

4 direct links

Weighted by public relations with evidence, recomputed daily.

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • RBD3133part of →Suzhou Ribo Life Science
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09 06:56
      RBD3133 stellt einen entscheidenden Meilenstein im siRNA-Entwicklungsportfolio von Ribo
      View source
  • Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09 06:56
      das sich auf die Entwicklung und Vermarktung von Therapeutika auf Basis kleiner interferierender RNA (siRNA) spezialisiert hat
      View source
    • CompanyPR Newswire news releases2026-10-08 18:44
      Suzhou Ribo Life Science Co. Ltd. (Ribo, 06938.HK) es una compañía biofarmacéutica global dedicada al desarrollo y la comercialización de terapias basadas en ARN de interferencia pequeño (siRNA).
      View source
  • Ribocure Pharmaceuticals ABpart of →Suzhou Ribo Life Science
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-11-10 13:59
      Suzhou Ribo Life Science (06938.HK) und seine Tochtergesellschaft Ribocure Pharmaceuticals AB (zusammen als „Ribo" bezeichnet)
      View source
    • CompanyPR Newswire news releases2026-11-10 09:00
      Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB
      View source
    • CompanyPR Newswire news releases2026-11-10 09:00
      Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo")
      View source
    • CompanyPR Newswire news releases2026-10-09 06:56
      Suzhou Ribo Life Science (06938.HK) und seine Tochtergesellschaft Ribocure Pharmaceuticals AB (zusammen als „Ribo" bezeichnet)
      View source
    • CompanyPR Newswire news releases2026-10-09 06:56
      Als ausländische Tochtergesellschaft von Suzhou Ribo Life Science
      View source
    • CompanyPR Newswire news releases2026-10-08 18:44
      Como filial en el extranjero de Suzhou Ribo Life Science, Ribocure Pharmaceuticals AB (Ribocure) se dedica al desarrollo global de terapias con oligonucleótidos que salvan vidas.
      View source
    • CompanyPR Newswire news releases2026-10-08 10:57
      Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB
      View source
    • CompanyPR Newswire news releases2026-10-08 09:41
      Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB
      View source
  • Suzhou Ribo Life Scienceagreement with →Madrigal Pharmaceuticals
    Fact55%
    View evidence
    • MediaGDELT Global Knowledge Graph2026-10-21 12:45
      View source

Showing 1 to 4 of 4

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 8

Suzhou Ribo Life Science (06938.HK) und seine Tochtergesellschaft Ribocure Pharmaceuticals AB (zusammen als „Ribo" bezeichnet)

PR Newswire news releases · 2026-11-10 13:59

View evidence
  • CompanyPR Newswire news releases2026-11-10 13:59
    Suzhou Ribo Life Science (06938.HK) und seine Tochtergesellschaft Ribocure Pharmaceuticals AB (zusammen als „Ribo" bezeichnet)
    View source
  • CompanyPR Newswire news releases2026-11-10 09:00
    Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB
    View source
  • CompanyPR Newswire news releases2026-11-10 09:00
    Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo")
    View source
  • CompanyPR Newswire news releases2026-10-09 06:56
    Suzhou Ribo Life Science (06938.HK) und seine Tochtergesellschaft Ribocure Pharmaceuticals AB (zusammen als „Ribo" bezeichnet)
    View source
  • CompanyPR Newswire news releases2026-10-09 06:56
    Als ausländische Tochtergesellschaft von Suzhou Ribo Life Science
    View source
  • CompanyPR Newswire news releases2026-10-08 18:44
    Como filial en el extranjero de Suzhou Ribo Life Science, Ribocure Pharmaceuticals AB (Ribocure) se dedica al desarrollo global de terapias con oligonucleótidos que salvan vidas.
    View source
  • CompanyPR Newswire news releases2026-10-08 10:57
    Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB
    View source
  • CompanyPR Newswire news releases2026-10-08 09:41
    Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB
    View source
FactEvidence 1

No public evidence summary is available.

GDELT Global Knowledge Graph · 2026-10-21 12:45

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-21 12:45
    View source
FactEvidence 2

das sich auf die Entwicklung und Vermarktung von Therapeutika auf Basis kleiner interferierender RNA (siRNA) spezialisiert hat

PR Newswire news releases · 2026-10-09 06:56

View evidence
  • CompanyPR Newswire news releases2026-10-09 06:56
    das sich auf die Entwicklung und Vermarktung von Therapeutika auf Basis kleiner interferierender RNA (siRNA) spezialisiert hat
    View source
  • CompanyPR Newswire news releases2026-10-08 18:44
    Suzhou Ribo Life Science Co. Ltd. (Ribo, 06938.HK) es una compañía biofarmacéutica global dedicada al desarrollo y la comercialización de terapias basadas en ARN de interferencia pequeño (siRNA).
    View source
FactEvidence 1
part ofRBD3133

RBD3133 stellt einen entscheidenden Meilenstein im siRNA-Entwicklungsportfolio von Ribo

PR Newswire news releases · 2026-10-09 06:56

View evidence
  • CompanyPR Newswire news releases2026-10-09 06:56
    RBD3133 stellt einen entscheidenden Meilenstein im siRNA-Entwicklungsportfolio von Ribo
    View source

Showing 1 to 4 of 4

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Suggest a page to watch

Know a page of this company that matters, such as pricing, a changelog, terms or careers? Suggest it. We read every suggestion; a page we add is watched for everyone, and we only count a change when two looks in a row agree.

Sign in to suggest a page

Not available: Company signals · Financials · Filings · Sites · Guidance